Endocrine Abstracts

There are increasing numbers of long-term survivors from breast cancer who will have received combination endocrine treatments alone or in addition to cytotoxic chemotherapy. As a result, many of these individuals are at increased risk of osteoporosis, largely because of the endocrine changes induced by treatment characterised by a reduction in the level of bioavailable oestradiol. The associated increase in bone turnover that accompanies cancer treatment induced bone loss (CT...

Background: Life expectancy of cancer survivors has doubled in the past four decades; however, death due to cardiovascular disease is more prevalent in survivors than the general population.Objective, design and methods: We evaluated novel and traditional cardiometabolic risk factors in young male cancer survivors in a cross-sectional study of male cancer survivors aged 25–45 years compared with age-matched non-cancer controls. Demographic and anthr...